Sartorius Stedim Biotech S.A.
SDMHF
$193.02
-$26.41-12.04%
OTC PK
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | 898.91M | 845.52M | 800.86M | 720.53M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 898.91M | 845.52M | 800.86M | 720.53M | |
| Cost of Revenue | 530.01M | 454.31M | 463.70M | 417.76M | |
| Gross Profit | 368.90M | 391.21M | 337.17M | 302.77M | |
| SG&A Expenses | 199.76M | 189.53M | 187.18M | 171.17M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -22.70M | 18.84M | -7.25M | 12.86M | |
| Total Operating Expenses | 743.97M | 699.12M | 683.18M | 642.81M | |
| Operating Income | 154.94M | 146.41M | 117.68M | 77.73M | |
| Income Before Tax | 90.45M | 104.98M | 43.60M | 39.03M | |
| Income Tax Expenses | 35.50M | 27.24M | -5.76M | 10.11M | |
| Earnings from Continuing Operations | 54.95M | 77.74M | 49.35M | 28.91M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | 116.40K | -- | -746.20K | -879.50K | |
| Net Income | 55.06M | 77.74M | 48.61M | 28.03M | |
| EBIT | 154.94M | 146.41M | 117.68M | 77.73M | |
| EBITDA | 161.69M | 234.82M | 130.69M | 161.50M | |
| EPS Basic | 0.57 | 0.78 | 0.50 | 0.29 | |
| Normalized Basic EPS | 0.68 | 0.66 | 0.50 | -- | |
| EPS Diluted | 0.57 | 0.78 | 0.50 | 0.29 | |
| Normalized Diluted EPS | 0.68 | 0.66 | 0.50 | -- | |
| Average Basic Shares Outstanding | 96.82M | 99.28M | 97.18M | 98.08M | |
| Average Diluted Shares Outstanding | 96.82M | 99.28M | 97.18M | 98.08M | |
| Dividend Per Share | 0.80 | -- | 0.74 | -- | |
| Payout Ratio | 0.00% | 97.96% | 0.00% | -- | |